Bovine papillomavirus E5 oncoprotein binds to the activated form of the platelet-derived growth factor β receptor in naturally occurring bovine urinary bladder tumours
- 3 October 2005
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 25 (8) , 1251-1260
- https://doi.org/10.1038/sj.onc.1209152
Abstract
Studies regarding the functions of the bovine papillomavirus (BPV) E5 oncoprotein in vivo are lacking and no E5-mediated mechanism underlying epithelial carcinogenesis is known. We have shown that BPV-2 DNA is present in the majority of naturally occurring urinary bladder tumours of cattle and that E5 is expressed in the cancer cells. Here we show that the interaction between the platelet-derived growth factor (PDGF) receptor and BPV E5, described in vitro in cultured cells, takes place in vivo in bovine urinary bladder cancers. In these cancers, E5 and PDGF receptor colocalize, as shown by confocal microscopy, and physically interact, as shown by coimmunoprecipitation. Furthermore, the PDGF receptor associated with E5 is highly phosphorylated, suggesting the functional activation of the receptor upon E5 interaction. Our results demonstrate, for the first time, that E5–PDGF receptor interaction occurs during the natural history of bovine urinary bladder tumours, suggesting an important role for E5 in carcinogenesis. Finally, the system provides a suitable animal model of papillomavirus-associated cancer to test therapeutic vaccination against E5. Successful bladder tumour regression would provide a valuable model for therapeutic vaccination against papillomavirus-associated tumours.Keywords
This publication has 53 references indexed in Scilit:
- Bovine Papillomavirus Type-2 (BPV-2) Infection and Expression of Uroplakin IIIb, a Novel Urothelial Cell Marker, in Urinary Bladder Tumors of CowsVeterinary Pathology, 2005
- Downregulation of major histocompatibility complex class I in bovine papillomasJournal of General Virology, 2004
- Cytotoxic-T-Lymphocyte Human Papillomavirus Type 16 E5 Peptide with CpG-Oligodeoxynucleotide Can Eliminate Tumor Growth in C57BL/6 MiceJournal of Virology, 2004
- Immunohistochemical Detection of Uroplakin III, Cytokeratin 7, and Cytokeratin 20 in Canine Urothelial TumorsVeterinary Pathology, 2003
- Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteinsOncogene, 2002
- The platelet-derived growth factor ß receptor as a target of the bovine papillomavirus E5 proteinCytokine & Growth Factor Reviews, 2000
- Bovine Papillomavirus E5 Protein Induces the Formation of Signal Transduction Complexes Containing Dimeric Activated Platelet-derived Growth Factor β Receptor and Associated Signaling ProteinsPublished by Elsevier ,2000
- Golgi Alkalinization by the Papillomavirus E5 OncoproteinThe Journal of cell biology, 2000
- Latent papillomavirus infection in cattleResearch in Veterinary Science, 1994
- Bovine papillomavirus E5 oncoprotein binds to the 16K component of vacuolar H+-ATPasesNature, 1991